- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/06 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies from serum
Patent holdings for IPC class C07K 16/06
Total number of patents in this class: 1092
10-year publication summary
|
64
|
82
|
125
|
95
|
77
|
91
|
77
|
60
|
48
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2713 |
41 |
| Regeneron Pharmaceuticals, Inc. | 4531 |
39 |
| Genentech, Inc. | 4045 |
35 |
| Amgen Inc. | 4304 |
34 |
| Cytiva BioProcess R&D AB | 313 |
32 |
| CSL Behring AG | 181 |
31 |
| Hoffmann-La Roche Inc. | 3620 |
30 |
| F. Hoffmann-La Roche AG | 7878 |
29 |
| Biotest AG | 111 |
21 |
| Bristol-myers Squibb Company | 4795 |
13 |
| Plasma Technologies, LLC | 28 |
13 |
| ADMA Biomanufacturing, LLC | 32 |
12 |
| AbbVie Biotechnology Ltd. | 177 |
11 |
| Janssen Biotech, Inc. | 1639 |
11 |
| The Johns Hopkins University | 5777 |
10 |
| Bio-Rad Laboratories, Inc. | 1612 |
10 |
| Momenta Pharmaceuticals, Inc. | 294 |
10 |
| EMD Millipore Corporation | 640 |
9 |
| Laboratoire Francais du Fractionnement et des Biotechnologies | 295 |
9 |
| The Rockefeller University | 584 |
9 |
| Other owners | 683 |